Showing 1-20 of 64 articles
Coronary interventions
Society of Thoracic Surgeons Risk Scores Performance in Patients with Left Main Coronary Artery Disease Undergoing Revascularization in the EXCEL trial August 20, 2019 | 10.4244/EIJ-D-19-00417
Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention
August 9, 2019 | 10.4244/EIJ-D-19-00262
Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial
August 9, 2019 | 10.4244/EIJ-D-19-00263
Coronary interventions
A Continuous Intracoronary Versus A Standard Intravenous Infusion of Adenosine for Fractional Flow Reserve Assessment – the HYPEREMIC Trial July 9, 2019 | 10.4244/EIJ-D-18-01067
Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention
June 11, 2019 | 10.4244/EIJ-D-19-00262
Does an Occluded RCA Affect Prognosis in Patients Undergoing PCI or CABG for Left Main Coronary Artery Disease? Analysis From the EXCEL Trial
June 11, 2019 | 10.4244/EIJ-D-19-00263
Treatment of mitral regurgitation: cut, clip or medicate?
April 16, 2019 | 10.4244/EIJV14I17A294
Coronary interventions
Significant association among residual SYNTAX score, non-culprit major adverse cardiac events, and greyscale and virtual histology intravascular ultrasound findings: a substudy from the PROSPECT study March 20, 2019 | 10.4244/EIJ-D-18-00681
Coronary interventions
Qualitative resting coronary pressure wave form analysis to predict fractional flow reserve February 7, 2019 | 10.4244/EIJ-D-17-01149
Coronary interventions
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial November 20, 2018 | 10.4244/EIJ-D-18-00711
Stents and scaffolds
Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial October 12, 2018 | 10.4244/EIJ-D-17-00716
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
August 3, 2018 | 10.4244/EIJ-D-17-00796
Coronary interventions
Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial August 3, 2018 | 10.4244/EIJ-D-18-00131
Coronary interventions
Pressure wire compared to microcatheter sensing for coronary fractional flow reserve: the PERFORM study July 20, 2018 | 10.4244/EIJ-D-18-00064
Coronary interventions
Acute and Long-term Relocation of Minimal Lumen Area after Bioresorbable Scaffold or Metallic Stent Implantation. July 4, 2018 | 10.4244/EIJ-D-18-00422
Stents and scaffolds
A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial May 20, 2018 | 10.4244/EIJ-D-17-00890
The effect of coronary bifurcation and haemodynamics in prediction of atherosclerotic plaque development: a serial computed tomographic coronary angiographic study
October 11, 2017 | 10.4244/EIJ-D-16-00929
Coronary interventions
State of the art: the inception, advent and future of fully bioresorbable scaffolds August 25, 2017 | 10.4244/EIJ-D-17-00499
